Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
about
Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort StudyPredictors of Adverse Outcomes in Children With Staphylococcus aureus BacteremiaObservation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.Molecular typing and phenotype characterization of methicillin-resistant Staphylococcus aureus isolates from blood in TaiwanHigh vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.The Japanese guidelines for the management of sepsis.Predictors of mortality in Staphylococcus aureus BacteremiaEffects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysisReduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.Population structure of colonizing and invasive Staphylococcus aureus strains in northern VietnamVancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis.Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospitalDaptomycin and methicillin-resistant Staphylococcus aureus isolated from a catheter-related bloodstream infection: a case report.Acute MRSA sinusitis with intracranial extension and marginal vancomycin susceptibility.Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility.Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory ConcentrationsHuman Safety and Environmental Concerns Associated with the Use of BiocidesApplication of a MALDI-TOF analysis platform (ClinProTools) for rapid and preliminary report of MRSA sequence types in TaiwanImpact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant bacteremia
P2860
Q28551659-CE748983-25D6-4B31-BEE9-E2C4A31FF865Q33806504-D66819BF-2CE7-44BE-B4B1-49756698778AQ33939095-7DC259B9-4750-412B-84B5-79DD7A93ED0DQ34146036-4BB86C1E-ED14-4E12-B097-6588BB712AE1Q34454418-F09F822B-F599-4EB7-862F-B64F1238A5ACQ35107094-C30E45D6-451F-4656-9AC4-D317D67A5DAAQ35940556-041A4A30-14CE-47CE-ACD7-10CDC826037CQ36078305-ADC0E08D-2FA0-4FB0-96F4-EFF9D124C34EQ36239533-2A8177C3-2C9B-4778-8943-F069D5FAB566Q36276932-BF05285C-5349-483C-BA05-B6D24BF9A680Q36456630-D386C071-F8B3-4687-99F4-C25884FF3B9FQ36565462-0B810617-FDB0-4ECF-B96D-2148C760C1D2Q36761108-C9E6797E-1DD7-4604-8A9E-36EB8BF71536Q37203845-AB36F116-BDEF-41F8-8B61-C3AEB88E41EDQ37544314-21953566-422A-4AD8-B7EB-190D727C0012Q37697213-F753DDCB-BF94-4819-BF32-27A95FBA7AEBQ37800310-8AEEB3A5-E176-42F2-84C4-0DFD43C161A7Q37981103-4C0F3AF0-F0AF-4C30-8EC0-D9B0385232C1Q37982066-62469CB0-3E1E-4AF6-8714-96945D9F2367Q39720219-77E6687B-B75E-494E-95D9-E117A750063AQ40320011-12AE652A-FE3A-4231-A265-8D3C8F3DCBEDQ41584600-0A762453-F6C0-41CB-9E8F-050655E6B5B6Q41689000-B328504B-650A-493D-B86A-C03FA6AC4B14Q42245059-5023FD26-7B77-4DDA-B302-F37FF2131001Q42524512-B304628F-5953-4E4E-992B-A38F197BE59BQ54392892-85165DBC-1DA8-4EE1-A12B-CC65743E4281Q55014868-963E9CA3-0192-4A96-BB5C-F9CCDD1FE518Q57763234-10352CBD-4F2D-4F5C-9F2A-B7F54E4AC9B1Q58624153-25ECFCB4-B1EA-4551-8B56-4AE71556970BQ58695771-93BF1448-EB96-4BEF-B8D1-3FF5EC727AABQ58777717-CF424AAE-F750-4893-B1AC-967195210EFF
P2860
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nosocomial methicillin-resista ...... the broth microdilution method
@ast
Nosocomial methicillin-resista ...... the broth microdilution method
@en
type
label
Nosocomial methicillin-resista ...... the broth microdilution method
@ast
Nosocomial methicillin-resista ...... the broth microdilution method
@en
prefLabel
Nosocomial methicillin-resista ...... the broth microdilution method
@ast
Nosocomial methicillin-resista ...... the broth microdilution method
@en
P2860
P50
P356
P1476
Nosocomial methicillin-resista ...... the broth microdilution method
@en
P2860
P2888
P356
10.1186/1471-2334-10-159
P577
2010-06-07T00:00:00Z
P5875
P6179
1053733886